معرفی
Professor Martin Griffin is a renowned biochemist and molecular biologist at Aston University's School of Biosciences, part of the College of Health and Life Sciences. He has dedicated over three decades to studying transglutaminases, enzymes critical for protein crosslinking in tissues like skin and blood clots. His research focuses on tissue transglutaminase (TG2), exploring its roles in cell death, fibrosis, tumor progression, and cystic fibrosis. He leads the Biosciences Research Group (BRG) and the Aston Research Centre for Health in Ageing, driving innovations in biomaterials for tissue repair. Griffin holds professional roles including President of the European Association for Higher Education in Biotechnology (2004) and Fellow of the Institute of Biology (2005).
Qualifications: BSc (1st class honours) in Applied Biology from the University of Salford (1970), PhD in Microbial Biochemistry from Aberystwyth University (1974).
Research Interests: Transglutaminase biochemistry, extracellular matrix dynamics, fibrosis mechanisms, biomaterial engineering, and enzyme-based therapies. His work bridges fundamental science and translational medicine, addressing clinical challenges like wound healing and organ regeneration. Recent projects include developing TG2 inhibitors for pulmonary fibrosis and using transglutaminases to engineer biocompatible materials.
Article Trends: Over 119 publications highlight his focus on TG2 inhibition's antifibrotic effects, zebrafish transglutaminase models, and mesothelioma cell signaling. Collaborations span oncology, immunology, and biomaterials engineering.
- Awards: Fellow of the Institute of Biology (2005), European Biotechnology Leadership Role (2004).
- Professional Activities: Peer review for EPSRC, REF 2014 panel member, and conference participation (e.g., EMBO Cellular Signaling 2012).
Labs/Teams: Leads interdisciplinary teams at Aston, integrating bioengineering and cellular biology to advance healthcare solutions.
